Global metabolomic analysis of heart tissue in a hamster model for dilated cardiomyopathy

Journal of Molecular and Cellular Cardiology

Volumn 59, Issue , 2013, Pages 76-85

  Maekawa, Keiko ^a   Hirayama, Akiyoshi ^b   Iwata, Yuko ^c   Tajima, Yoko ^a   Nishimaki Mogami, Tomoko ^a   Sugawara, Shoko ^b   Ueno, Noriko ^a   Abe, Hiroshi ^b   Ishikawa, Masaki ^a   Murayama, Mayumi ^a   Matsuzawa, Yumiko ^a   Nakanishi, Hiroki ^a,d   Ikeda, Kazutaka ^b   Arita, Makoto ^a,e   Taguchi, Ryo ^a,f   Minamino, Naoto ^c   Wakabayashi, Shigeo ^c   Soga, Tomoyoshi ^b   Saito, Yoshiro ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^d AKITA UNIVERSITY   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

^f CHUBU UNIVERSITY   (Japan)

Author keywords

Dilated cardiomyopathy; Hamster model; Metabolomics; Oxidative stress; Phospholipid alteration

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; DELTA SARCOGLYCAN; GLUTATHIONE; GLUTATHIONE DERIVATIVE; ICOSANOID; MEMBRANE PHOSPHOLIPID; OPHTHALMATE; PROSTAGLANDIN E2; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; PHOSPHOLIPID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY ELECTROPHORESIS; CARDIAC MUSCLE; CITRIC ACID CYCLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; ENERGY METABOLISM; GENE DELETION; GLUTATHIONE METABOLISM; GLYCOLYSIS; HAMSTER MODEL; HEART CONTRACTION; HEART LEFT VENTRICLE; HEART TISSUE; HISTOCHEMISTRY; LIPID HOMEOSTASIS; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; MALE; MASS SPECTROMETRY; METABOLOMICS; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SURFACE CHARGE; ANIMAL; DISEASE MODEL; HAMSTER; LIQUID CHROMATOGRAPHY; METABOLISM; METHODOLOGY; PHYSIOLOGY;

ANIMALS; CARDIOMYOPATHY, DILATED; CHROMATOGRAPHY, LIQUID; CRICETINAE; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, CAPILLARY; MASS SPECTROMETRY; METABOLOMICS; OXIDATIVE STRESS; PHOSPHOLIPIDS;

EID: 84874935448     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2013.02.008     Document Type: Article

References (39)

1. Luk, A., Ahn, E., Soor, G.S., Butany, J., Dilated cardiomyopathy: a review. J Clin Pathol 62 (2009), 219–225.
2. Tigen, K., Cevik, C., Beta-blockers in the treatment of dilated cardiomyopathy: which is the best?. Curr Pharm Des 16 (2010), 2866–2871.
3. Takeda, N., Cardiomyopathy: molecular and immunological aspects (review). Int J Mol Med 11 (2003), 13–16.
4. Seidman, J.G., Seidman, C., The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell 104 (2001), 557–567.
5. Campbell, K.P., Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage. Cell 80 (1995), 675–679.
6. Yucel, D., Aydogdu, S., Senes, M., Topkaya, B.C., Nebioglu, S., Evidence of increased oxidative stress by simple measurements in patients with dilated cardiomyopathy. Scand J Clin Lab Invest 62 (2002), 463–468.
7. Demirbag, R., Yilmaz, R., Erel, O., Gultekin, U., Asci, D., Elbasan, Z., The relationship between potency of oxidative stress and severity of dilated cardiomyopathy. Can J Cardiol 21 (2005), 851–855.
8. Baumer, A.T., Flesch, M., Wang, X., Shen, Q., Feuerstein, G.Z., Bohm, M., Antioxidative enzymes in human hearts with idiopathic dilated cardiomyopathy. J Mol Cell Cardiol 32 (2000), 121–130.
9. Mitsuhashi, S., Saito, N., Watano, K., Igarashi, K., Tagami, S., Shima, H., et al. Defect of delta-sarcoglycan gene is responsible for development of dilated cardiomyopathy of a novel hamster strain, J2N-k: calcineurin/PP2B activity in the heart of J2N-k hamster. J Biochem 134 (2003), 269–276.
10. Soga, T., Baran, R., Suematsu, M., Ueno, Y., Ikeda, S., Sakurakawa, T., et al. Differential metabolomics reveals ophthalmic acid as an oxidative stress biomarker indicating hepatic glutathione consumption. J Biol Chem 281 (2006), 16768–16776.
11. Nakamura, K., Kusano, K., Nakamura, Y., Kakishita, M., Ohta, K., Nagase, S., et al. Carvedilol decreases elevated oxidative stress in human failing myocardium. Circulation 105 (2002), 2867–2871.
12. Fujii, T., Onohara, N., Maruyama, Y., Tanabe, S., Kobayashi, H., Fukutomi, M., et al. Galpha12/13-mediated production of reactive oxygen species is critical for angiotensin receptor-induced NFAT activation in cardiac fibroblasts. J Biol Chem 280 (2005), 23041–23047.
13. Soga, T., Igarashi, K., Ito, C., Mizobuchi, K., Zimmermann, H.P., Tomita, M., Metabolomic profiling of anionic metabolites by capillary electrophoresis mass spectrometry. Anal Chem 81 (2009), 6165–6174.
14. Soga, T., Heiger, D.N., Amino acid analysis by capillary electrophoresis electrospray ionization mass spectrometry. Anal Chem 72 (2000), 1236–1241.
15. Bligh, E.G., Dyer, W.J., A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37 (1959), 911–917.
16. Taguchi, R., Ishikawa, M., Precise and global identification of phospholipid molecular species by an Orbitrap mass spectrometer and automated search engine Lipid Search. J Chromatogr A 1217 (2010), 4229–4239.
17. Sugimoto, M., Wong, D.T., Hirayama, A., Soga, T., Tomita, M., Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics 6 (2010), 78–95.
18. Ono, M., Shitashige, M., Honda, K., Isobe, T., Kuwabara, H., Matsuzuki, H., et al. Label-free quantitative proteomics using large peptide data sets generated by nanoflow liquid chromatography and mass spectrometry. Mol Cell Proteomics 5 (2006), 1338–1347.
19. Gulston, M.K., Rubtsov, D.V., Atherton, H.J., Clarke, K., Davies, K.E., Lilley, K.S., et al. A combined metabolomic and proteomic investigation of the effects of a failure to express dystrophin in the mouse heart. J Proteome Res 7 (2008), 2069–2077.
20. Nakae, I., Mitsunami, K., Yoshino, T., Yoshino, T., Omura, T., Tsutamoto, T., et al. Clinical features of myocardial triglyceride in different types of cardiomyopathy assessed by proton magnetic resonance spectroscopy: comparison with myocardial creatine. J Card Fail 16 (2010), 812–822.
21. Missihoun, C., Zisa, D., Shabbir, A., Lin, H., Lee, T., Myocardial oxidative stress, osteogenic phenotype, and energy metabolism are differentially involved in the initiation and early progression of delta-sarcoglycan-null cardiomyopathy. Mol Cell Biochem 321 (2009), 45–52.
22. Aruoma, O.I., Halliwell, B., Hoey, B.M., Butler, J., The antioxidant action of taurine, hypotaurine and their metabolic precursors. Biochem J 256 (1988), 251–255.
23. Takarada, S., Imanishi, T., Goto, M., Mochizuki, S., Ikejima, H., Tsujioka, H., et al. First evaluation of real-time nitric oxide changes in the coronary circulation in patients with non-ischaemic dilated cardiomyopathy using a catheter-type sensor. Eur Heart J 31 (2010), 2862–2870.
24. Zima, A.V., Blatter, L.A., Redox regulation of cardiac calcium channels and transporters. Cardiovasc Res 71 (2006), 310–321.
25. Wende, A.R., Abel, E.D., Lipotoxicity in the heart. Biochim Biophys Acta 2010 (1801), 311–319.
26. Jenkins, C.M., Cedars, A., Gross, R.W., Eicosanoid signalling pathways in the heart. Cardiovasc Res 82 (2009), 240–249.
27. Okumura, K., Yamada, Y., Kondo, J., Hashimoto, H., Ito, T., Kitoh, J., Decreased 1,2-diacylglycerol levels in myopathic hamster hearts during the development of heart failure. J Mol Cell Cardiol 23 (1991), 409–416.
28. Fu, S., Yang, L., Li, P., Hofmann, O., Dicker, L., Hide, W., et al. Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity. Nature 473 (2011), 528–531.
29. Babick, A.P., Cantor, E.J., Babick, J.T., Takeda, N., Dhalla, N.S., Netticadan, T., Cardiac contractile dysfunction in J2N-k cardiomyopathic hamsters is associated with impaired SR function and regulation. Am J Physiol Cell Physiol 287 (2004), C1202–C1208.
30. Yu, L., Netticadan, T., Xu, Y.J., Panagia, V., Dhalla, N.S., Mechanisms of lysophosphatidylcholine-induced increase in intracellular calcium in rat cardiomyocytes. J Pharmacol Exp Ther 286 (1998), 1–8.
31. Pewzner-Jung, Y., Ben-Dor, S., Futerman, A.H., When do Lasses (longevity assurance genes) become CerS (ceramide synthases)?: insights into the regulation of ceramide synthesis. J Biol Chem 281 (2006), 25001–25005.
32. Gramolini, A.O., Kislinger, T., Alikhani-Koopaei, R., Fong, V., Thompson, N.J., Isserlin, R., et al. Comparative proteomics profiling of a phospholamban mutant mouse model of dilated cardiomyopathy reveals progressive intracellular stress responses. Mol Cell Proteomics 7 (2008), 519–533.
33. Banke, N.H., Wende, A.R., Leone, T.C., O'Donnell, J.M., Abel, E.D., Kelly, D.P., et al. Preferential oxidation of triacylglyceride-derived fatty acids in heart is augmented by the nuclear receptor PPARalpha. Circ Res 107 (2010), 233–241.
34. Dávila-Román, V.G., Vedala, G., Herrero, P., de las Fuentes, L., Rogers, J.G., Kelly, D.P., et al. Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy. J Am Coll Cardiol 40 (2002), 271–277.
35. Martin, M., Meyer-Kirchrath, J., Kaber, G., Jacoby, C., Flögel, U., Schrader, J., et al. Cardiospecific overexpression of the prostaglandin EP3 receptor attenuates ischemia-induced myocardial injury. Circulation 112 (2005), 400–406.
36. Xiao, C.Y., Yuhki, K., Hara, A., Fujino, T., Kuriyama, S., Yamada, T., et al. Prostaglandin E2 protects the heart from ischemia-reperfusion injury via its receptor subtype EP4. Circulation 109 (2004), 2462–2468.
37. Harding, P., Yang, X.P., Yang, J., Shesely, E., He, Q., LaPointe, M.C., Gene expression profiling of dilated cardiomyopathy in older male EP4 knockout mice. Am J Physiol Heart Circ Physiol 298 (2010), H623–H632.
38. Drelicharz, L., Kozlovski, V., Skorka, T., Heinze-Paluchowska, S., Jasinski, A., Gebska, A., et al. NO and PGI(2) in coronary endothelial dysfunction in transgenic mice with dilated cardiomyopathy. Basic Res Cardiol 103 (2008), 417–430.
39. Xiao, C.Y., Hara, A., Yuhki, K., Fujino, T., Ma, H., Okada, Y., et al. Roles of prostaglandin I(2) and thromboxane A(2) in cardiac ischemia-reperfusion injury: a study using mice lacking their respective receptors. Circulation 104 (2001), 2210–2225.